I n an open, p r o s p e c t i v e , non-comparative s t u d y , 37 p r e v i o u s l y t r e a t e d (PrTr) (with e x t r a c t e d HGH) and 5 p r e v i o u s l y u n t r e a t e d (PrUn) GHD c h i l d r e n ( h e i g h t (Ht) < 3 p e r c e n t i l e o r Ht v e l o c i t y (Vel) < 4 cmJyear; max.serum-GH < 10 ng/ml i n a t l e a s t two s t a ndard s t i m u l a t i o n t e s t s ) were given Bio-HGH (Somatropin-Lilly) s.c.0.06 mg/kg t h r e e times a week t o a max. of 8 mg p e r week. Treatment w i t h Bio-HGH began a t l e a s t 5 months a f t e r t r e a t m e n t w i t h e x t r a c t e d HGII had ceased. Height was measured w j t h i n 2 months a f t e r previous t r e a t m e n t was discontinued. Lower l e g l e n g t h (LLL) measurements were s t a r t e d 6 weeks b e f o r e t r e a t m e n t w i t h Bio-HGII by u s i n g a knemometer. Ht Vel (cmlyr) and LLL Vel (nnn/yr) a r e shown i n the t a b l e (mean+SD).
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EFFICACY OF BIOSYNIMETIC HUMAN GROWTH HORMONE (BIO-IIGH) I N STIMULATING GROWTH I N PREPUBERTAL (PRE) AND PUBERTAL (PUB) CHILDREN WITlI GROWTll HORMONE DEFICIENCY (GHD)
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Before Bio-HGH 13 weeks Bio-HGH Group n LLL Vel Ht Vel LLL Vel Ht Vel P r U n P r e 5 1 4 . 3 i 6 . 0 3.2'2.0 35.0'9.5 10.0'3.2 PrTr Pre 24 11.11 8.2 1.4+ 1.9 33.61 8.0 9.4+ 2.5 Pub 13 9.8i10.2 2.6i 2.5 25.3' 8.9 8 . 2 i 2.7 LLL Vel c o r r e l a t e d more s i g n i f i c a n t l y w i t h l l t Vel d u r i n g (r=O. 75) than b e f o r e (r=0.47) Bio-1IGH treatment. Because LLL was measured only 6 weeks b e f o r e Bio-HGH was s t a r t e d , the LLL Vel probably r e f l e c t s more a c c u r a t e l y the e f f i c a c y of Bio-11GH i n PrTr p a t i e n t s . 192-rhGH (Somatrem) w i t h ECPC of 285-1400 ( S I ) , 170-30 ( S 1 I ) a n d (10 ( S I I I ) / n g / v i a l was used i n 3 s t u d i e s i n GHDP n o t p r e v i o u s l y ("new") o r p r e v i o u s l y ("old") t r e a t e d w i t h pit-hGM. I n 8 "old" pat i e n t s ( d u r a t i o n l month ( m ) ) , g l u c o s e and i n s u l i n responses i n t h e OGTT, i n s u l i n b i n d i n g i n e r y t h r o c y t e s and somatomedin a c t i v i t y (SMA) were s i m i l a r on pit-hGH o r S I . Absence o f hGH-antibodies (hGB-ab) d u r i n g t h i s p e r i o d . On S I I ( 9 p a t i e n t s , d u r a t i o n 9-12 m.) and S I I I (21 p a t i e n t s , planned d u r a t i o n 1 y e a r , r e s u l t s p r e s e n t e d of 6 m ) , "new" p a t i e n t s experimented t y p i c a l catch-up growth and t h e o l d ones maintained t h e i r p r e v i o u s growth v e l o c i t y (g.v.1. SMA c o r r e l a t e d w i t h g.v. and a d u l t h e i g h t prognosis improved throughout t r e a t m e n t . hGH-ab t e s t was p o s i t i v e on S I I a t 3 m. of t r e a t m e n t i n 77% o f c a s e s and i n 88% a t 9-12 m., while on S I I I a t 3 m. and 6 m. hGH-ab t e s t was p o s i t i v e i n o n l y 8 % and 16% of c a s e s n o t prev i o u s l y t r e a t e d w i t h S I I b u t again i n 88% of p a t i e n t s p r e v i o u s l y t r e a t e d w i t h S I I . Binding c a p a c i t y of hGH-ab was v e r y low. ECP-ab were a l r e a d y p o s i t i v e i n 33% a t o n s e t and i n c r e a s e d moderately l at e r . Thus 192-rhGH promotes g .~. and SMA and, a s i n t h e m a j o r i t y of c a s e s hGH-ab t e s t i s a l r e a d y p o s i t i v e a t 3 m., S I I I i s c l e a r l y l e s s a n t i g e n i c than S I I . P a t i e n t s p r e v i o u s l y t r e a t e d w i t h S I I poss i b l y developed an anamnestic response on S I I I . No o t h e r s i d e e f f e c t s were observed. 
COMPARISON OF THE LIPOLYTIC POTENCY OF PITUITARY-DERIVED AND BIOSYNTHETIC GROWTH HORMONE I N HYPOPITUI-TAKY CHILDREN.

Whether l i p o l y s i s i s an i n t r i n s i c p r o p e r t y of t h e growth hormone (GH) molecule o r i s due t o contaminants of p i t u i t a r y o r i g i n remains c o n t r o v e r s i a l . We t h e r e f o r e compared t h e r i s e i n plasma f r e e f a t t y a c i d (FFA) l e v e l s measured w i t h t h e Nefa Quick "BMY" k i t , Boehringer) induced by e i t h e r p i t u i t a r y G H (pit-GH, Nanormon, Nordisk) o r b i o s~n t h e t i c G H (syn-GH, Somatonorm, Kabi)
i n 34 h y p o p i t u i t a r y c h i l d r e n (age 5 -18 y e a r s , peak plasma GH < 5 ng/ml a f t e r i n s u l i n and glucagon t o l e r a n c e t e s t s ) . The p a t i e n t s were admitted a f t e r an o v e r n i g h t f a s t and f a s t e d u n t i l 1230 h r on both s t u d y days. On day 1 , no i n j e c t i o n was given. On day 2, 0 . 2 U/kg of e i t h e r pit-GH (N=5, group A) o r syn-GI4 (N=29, group B) was given IEI a t 0830 h r . The FFA l e v e l s a t 1230 h r a r e expressed a s % of t h e 0830 h r v a l u e . I n group A, mean (+ SEM) plasma FFA l e v e l s a t 1230 h r were 138.7 + 9.8 % of the0830 h r v a l u e on day 1 and 233.1 + 20.0 % on day 2. I n group B, they were 130.3 + 10.9 % and 267 + 22.6 % on days 1 and 2, r e s p e c t i v e l y . Thus, both G H p r e p a r a t i o n s induced a r i s e i n plasma FFA l e v e l s g r e a t e r than t h a t induced by f a s t i n g a l o n e (p < 0.001) but t h e two G H p r e p a r a t i o n s were n o t s i g n i f i c a n t l y d i f f e r e n t from each o t h e r (p > 0 . 2 ) . We conclude t h a t t h e a c u t e l i p o l y t i c e f f e c t probably r e p r e s e n t s an i n t r i n s i c property of t h e G H molecule. University of Bonn, I n s t i t u t e f o r C l i n i c a l Biochemistry, Bonn, University of Munich, C h i l d r e n ' s Hospital and I n s t i t u t e f o r Forensic Pathology, Munich, FRG.
SEX DIFFtRENCES IN GONADAL ESTRADIOL (E2) AND ESTRONE ( E l ) CONCENTRATIONS IN INFANCY
To c l a r i f y t h e o r i g i n of e s t r o g e n s i n i n f a n t blood, we measured El and E2 i n t h e gonads of 50 g i r l s and 64 boys deceased by sudden death between b i r t h and 2 y e a r s of age. I n both s e x e s , E2 w a s ' t h e major gonadal e s t r o g e n which exceeded El almost t e n f o l d in t h e o v a r i e s and t w i c e i n t h e testes. Thus, t h e r e was a c l e a r sex d i f f e r e n c e i n gonadal e s t r o g e n c o n c e n t r a t i o n s . On an average, g i r l s had 8 t i m e s higher E2 and t w i c e a s high El c o n c e n t r a t i o n s in t h e i r gonads than boys. As i n plasma, E2 c o n c e n t r a t i o n s were h i g h e s t i n o v a r i e s of 2 t o 4 months o l d g i r l s ( 2 -55 n g l g ) and in t e s t e s of 1 t o 3 months o l d boys ( 0 . 6 -6.4 n g l g ) . Ovarian E2 c o n c e n t r a t i o n s decreased t o v a l u e s below 3 nglg u n t i l t h e end of t h e 1 s t y e a r of l i f e , t e s t i c u l a r E2 reached values below 1 nglg a l r e a d y by 6 months of age. The gonadal s t e r o i d o g e n i c a c t i v i t y p a r a l l e l e d changes i n gonadal morphology. Ovarian weights showed a s i m i l a r p a t t e r n of r i s e and f a l l a s t h e E2 conc e n t r a t i o n s , t h e b i g g e s t o v a r i e s c o n s i s t i n g of m u l t i p l e rnacroscopic c y s t s . In boys, t e s t i c u l a r €2 c l o s e l y c o r r e l a t e d with Leydig c e l l development and t e s t i c u l a r t e s t o s t e r o n e c o n c e n t r a tions. W e conclude t h a t t h e s u r g e of €2 in t h e blood of i n f a n t g i r l s and boys o r i g i n a t e s from o v a r i a n f o l l i c l e s and t e s t i c u l a r Leydig c e l l s , r e s p e c t i v e l y , which develop under t h e i n f l u e n c e of the c h a r a c t e r i s t i c p o s t -n a t a l gonadotropin surge.
